The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: MLB Forecasting, Stanley Cup Hockey Analytics, & the French Open

Ep. 151

Show from 5/22/19


In this episode of Wharton Moneyball hosts Shane Jensen and Adi Wyner kick off the show alone and switch things up by discussing things that DID NOT catch their eye in sports. Then they get into MLB forecasting and the NBA Eastern Conference Finals. Next they bring on Hockey Analyst for TSN and NHL Network Mike Kelly to talk about the Stanley Cup from evaluating coaches to analyzing goalies. Plus host Eric Bradlow crashes the show during the second hour and they talk to Craig O’Shannessy about the French Open and tennis news. Tune in!


Guests:

Mike Kelly is a Hockey Analyst for TSN and NHL Network. He also works with the data driven story telling platform The Point and he has a particular focus on hockey analytics.

Follow him on Twitter: @MikeKellyNHL


Craig O’Shannessy is widely recognized as the world leader in teaching and analyzing tennis strategy. Craig is the strategy analyst for the ATP Tour, Wimbledon, the Australian Open, Team Djokovic and The New York Times. He is also the founder of Brain Game Tennis.

Follow him on Twitter: @BrainGameTennis

More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.